Literature DB >> 2109037

cis-acting sequences required for class II gene regulation by interferon gamma and tumor necrosis factor alpha in a murine macrophage cell line.

Y R Freund1, R L Dedrick, P P Jones.   

Abstract

In this report, we have demonstrated that IFN-gamma and TNF-alpha increase expression of both the I-A and I-E region gene products on the surface of the myelomonocytic cell line WEHI-3, and that they mediate this increase via an increase in A alpha transcription. Constructs containing 5' deletion mutations of the A alpha promoter attached to the bacterial chloramphenicol acetyl transferase gene were used to delineate the minimum 5' flanking sequences required for promoter activity, and for inducibility by IFN-gamma and TNF-alpha. Approximately 115 bp of 5' sequences are required for minimum induction by IFN-gamma or TNF-alpha when the cytokines are present separately. This includes the three conserved promoter elements, the X, Y, and H boxes. Nested linker-scanner mutations demonstrated that additional regions were also critical for optimal induction by IFN-gamma or TNF-alpha. These include the kappa B-like enhancer and a TNF-alpha-specific sequence that we have tentatively called the T box. The T box sequence was also found in the promoter regions of the human HLA-DQ alpha and rat RT1.B alpha genes. Although the entire T box sequence element was not found in the other mouse class II genes, all class II alpha genes contained the SV40 core enhancer element in the regions included by the T box. Mouse class II beta genes appear to contain neither the T box nor the core enhancer element in this region, suggesting differential regulation of class II alpha and beta genes by TNF-alpha.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2109037      PMCID: PMC2187825          DOI: 10.1084/jem.171.4.1283

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  57 in total

1.  A transplantable myelomonocytic leukemia in BALB-c mice: cytology, karyotype, and muramidase content.

Authors:  N L Warner; M A Moore; D Metcalf
Journal:  J Natl Cancer Inst       Date:  1969-10       Impact factor: 13.506

2.  Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens.

Authors:  V T Oi; P P Jones; J W Goding; L A Herzenberg; L A Herzenberg
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

3.  A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene.

Authors:  S D Gillies; S L Morrison; V T Oi; S Tonegawa
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

4.  Structure and nucleotide sequence of the heavy chain gene of HLA-DR.

Authors:  H K Das; S K Lawrance; S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

5.  Monoclonal antibodies to mouse major histocompatibility complex antigens.

Authors:  K Ozato; N M Mayer; D H Sachs
Journal:  Transplantation       Date:  1982-09       Impact factor: 4.939

6.  Structure of the murine immune response I-A beta locus: sequence of the I-A beta gene and an adjacent beta-chain second domain exon.

Authors:  D Larhammar; U Hammerling; M Denaro; T Lund; R A Flavell; L Rask; P A Peterson
Journal:  Cell       Date:  1983-08       Impact factor: 41.582

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens.

Authors:  K Ozato; N Mayer; D H Sachs
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

10.  Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition.

Authors:  J W Kappler; B Skidmore; J White; P Marrack
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

View more
  11 in total

1.  Transcriptional control of the invariant chain gene involves promoter and enhancer elements common to and distinct from major histocompatibility complex class II genes.

Authors:  L Zhu; P P Jones
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

2.  Structure and evolution of the promoter regions of the DQA genes.

Authors:  E Morzycka-Wroblewska; J I Harwood; J R Smith; M F Kagnoff
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

Review 3.  Current concepts in DRA gene regulation.

Authors:  J P Ting
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

4.  High GILT Expression and an Active and Intact MHC Class II Antigen Presentation Pathway Are Associated with Improved Survival in Melanoma.

Authors:  Kenneth H Buetow; Lydia R Meador; Hari Menon; Yih-Kuang Lu; Jacob Brill; Haiyan Cui; Denise J Roe; David J DiCaudo; K Taraszka Hastings
Journal:  J Immunol       Date:  2019-10-07       Impact factor: 5.422

5.  Tumor necrosis factor alpha response elements in the HLA-DRA promoter: identification of a tumor necrosis factor alpha-induced DNA-protein complex in astrocytes.

Authors:  R B Panek; H Moses; J P Ting; E N Benveniste
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

6.  Delineation of a previously unrecognized cis-acting element required for HLA class II gene expression.

Authors:  M Sugawara; P D Ponath; J Shin; Z Yang; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

7.  Pattern of graft- and host-specific MHC class II expression in long-term murine cardiac allografts: origin of inflammatory and vascular wall cells.

Authors:  S Hasegawa; G Becker; H Nagano; P Libby; R N Mitchell
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

8.  Identification of a transcription factor that binds to the S box of the I-A beta gene of the major histocompatibility complex.

Authors:  A Celada; P Gil; S R McKercher; R A Maki
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

9.  Repression of class II major histocompatibility complex genes by cyclic AMP is mediated by conserved promoter elements.

Authors:  L B Ivashkiv; L H Glimcher
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

10.  Specific suppression of major histocompatibility complex class I and class II genes in astrocytes by brain-enriched gangliosides.

Authors:  P T Massa
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.